Merit Medical’s Embosphere® Microspheres Receive FDA 513(f)(2) (de novo) Classification for Prostatic Artery Embolization Indication

http://www.globenewswire.com/news-release/2017/06/22/1027738/0/en/Merit-Medical-s-Embosphere-Microspheres-Receive-FDA-513-f-2-de-novo-Classification-for-Prostatic-Artery-Embolization-Indication.html?f=22&fvtc=5&fvtv=44970140